Effects of Calcitonin Gene-Related Peptide on Renal Blood Flow in the Rat

Daniel Villarreal, Ronald H. Freeman, Kenneth M. Verburg, Michael W. Brands

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

The effects of α-rat calcitonin gene-related peptide (α-rCGRP) on systemic and renal hemodynamics and on renal electrolyte excretion were examined in normal anesthetized rats. In one group of rats (n = 7), infusions of α-rCGRP at doses of 10, 50, 100, and 500 ng/kg/min for 15 min each produced dose-related and significant decreases in mean arterial pressure from a control of 130 ± 3 mm Hg to a maximal depressor response of 91 ± 2 mm Hg. During the first three doses of α-rCGRP, renal blood flow progressively and significantly increased from a control of 5.0 ± 0.3 ml/min to a peak level of 6.3 ± 0.3 ml/min achieved during the 100 ng/kg/min infusion. With the highest infusion rate of 500 ng/kg/min, renal blood flow fell below the control level to 4.5 ± 0.2 ml/min (P < 0.05). The responses in renal blood flow and mean arterial pressure were associated with reductions in renal vascular resistance. After cessation of α-rCGRP infusions, arterial pressure, renal blood flow, and renal vascular resistance gradually returned toward the baseline values. In another group of rats (n = 9), infusion of α-rCGRP for 30 min at 100 ng/kg/min produced a significant reduction in urinary sodium excretion from 0.28 ± 0.06 to 0.14 ± 0.5 μEq/min (P < 0.05). Urine flow and urinary potassium excretion also appeared to decrease, but the changes were not significantly different (P > 0.05) from their respective baselines. These results demonstrate that α-rCGRP is a potent and reversible hypotensive and renal vasodilatory agent in the anesthetized rat. The data also suggest that α-rCGRP may have significant effects on the excretory function of the kidney.

Original languageEnglish (US)
Pages (from-to)316-322
Number of pages7
JournalProceedings of the Society for Experimental Biology and Medicine
Volume188
Issue number3
DOIs
StatePublished - Jul 1988

Fingerprint

Calcitonin Gene-Related Peptide
Renal Circulation
Rats
Blood
Renal Agents
Kidney
Level control
Hemodynamics
Electrolytes
Arterial Pressure

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Effects of Calcitonin Gene-Related Peptide on Renal Blood Flow in the Rat. / Villarreal, Daniel; Freeman, Ronald H.; Verburg, Kenneth M.; Brands, Michael W.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 188, No. 3, 07.1988, p. 316-322.

Research output: Contribution to journalArticle

Villarreal, Daniel ; Freeman, Ronald H. ; Verburg, Kenneth M. ; Brands, Michael W. / Effects of Calcitonin Gene-Related Peptide on Renal Blood Flow in the Rat. In: Proceedings of the Society for Experimental Biology and Medicine. 1988 ; Vol. 188, No. 3. pp. 316-322.
@article{646eb35ba448413880286ae8c8dd06b5,
title = "Effects of Calcitonin Gene-Related Peptide on Renal Blood Flow in the Rat",
abstract = "The effects of α-rat calcitonin gene-related peptide (α-rCGRP) on systemic and renal hemodynamics and on renal electrolyte excretion were examined in normal anesthetized rats. In one group of rats (n = 7), infusions of α-rCGRP at doses of 10, 50, 100, and 500 ng/kg/min for 15 min each produced dose-related and significant decreases in mean arterial pressure from a control of 130 ± 3 mm Hg to a maximal depressor response of 91 ± 2 mm Hg. During the first three doses of α-rCGRP, renal blood flow progressively and significantly increased from a control of 5.0 ± 0.3 ml/min to a peak level of 6.3 ± 0.3 ml/min achieved during the 100 ng/kg/min infusion. With the highest infusion rate of 500 ng/kg/min, renal blood flow fell below the control level to 4.5 ± 0.2 ml/min (P < 0.05). The responses in renal blood flow and mean arterial pressure were associated with reductions in renal vascular resistance. After cessation of α-rCGRP infusions, arterial pressure, renal blood flow, and renal vascular resistance gradually returned toward the baseline values. In another group of rats (n = 9), infusion of α-rCGRP for 30 min at 100 ng/kg/min produced a significant reduction in urinary sodium excretion from 0.28 ± 0.06 to 0.14 ± 0.5 μEq/min (P < 0.05). Urine flow and urinary potassium excretion also appeared to decrease, but the changes were not significantly different (P > 0.05) from their respective baselines. These results demonstrate that α-rCGRP is a potent and reversible hypotensive and renal vasodilatory agent in the anesthetized rat. The data also suggest that α-rCGRP may have significant effects on the excretory function of the kidney.",
author = "Daniel Villarreal and Freeman, {Ronald H.} and Verburg, {Kenneth M.} and Brands, {Michael W.}",
year = "1988",
month = "7",
doi = "10.3181/00379727-188-42740",
language = "English (US)",
volume = "188",
pages = "316--322",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "1535-3702",
publisher = "Society for Experimental Biology and Medicine",
number = "3",

}

TY - JOUR

T1 - Effects of Calcitonin Gene-Related Peptide on Renal Blood Flow in the Rat

AU - Villarreal, Daniel

AU - Freeman, Ronald H.

AU - Verburg, Kenneth M.

AU - Brands, Michael W.

PY - 1988/7

Y1 - 1988/7

N2 - The effects of α-rat calcitonin gene-related peptide (α-rCGRP) on systemic and renal hemodynamics and on renal electrolyte excretion were examined in normal anesthetized rats. In one group of rats (n = 7), infusions of α-rCGRP at doses of 10, 50, 100, and 500 ng/kg/min for 15 min each produced dose-related and significant decreases in mean arterial pressure from a control of 130 ± 3 mm Hg to a maximal depressor response of 91 ± 2 mm Hg. During the first three doses of α-rCGRP, renal blood flow progressively and significantly increased from a control of 5.0 ± 0.3 ml/min to a peak level of 6.3 ± 0.3 ml/min achieved during the 100 ng/kg/min infusion. With the highest infusion rate of 500 ng/kg/min, renal blood flow fell below the control level to 4.5 ± 0.2 ml/min (P < 0.05). The responses in renal blood flow and mean arterial pressure were associated with reductions in renal vascular resistance. After cessation of α-rCGRP infusions, arterial pressure, renal blood flow, and renal vascular resistance gradually returned toward the baseline values. In another group of rats (n = 9), infusion of α-rCGRP for 30 min at 100 ng/kg/min produced a significant reduction in urinary sodium excretion from 0.28 ± 0.06 to 0.14 ± 0.5 μEq/min (P < 0.05). Urine flow and urinary potassium excretion also appeared to decrease, but the changes were not significantly different (P > 0.05) from their respective baselines. These results demonstrate that α-rCGRP is a potent and reversible hypotensive and renal vasodilatory agent in the anesthetized rat. The data also suggest that α-rCGRP may have significant effects on the excretory function of the kidney.

AB - The effects of α-rat calcitonin gene-related peptide (α-rCGRP) on systemic and renal hemodynamics and on renal electrolyte excretion were examined in normal anesthetized rats. In one group of rats (n = 7), infusions of α-rCGRP at doses of 10, 50, 100, and 500 ng/kg/min for 15 min each produced dose-related and significant decreases in mean arterial pressure from a control of 130 ± 3 mm Hg to a maximal depressor response of 91 ± 2 mm Hg. During the first three doses of α-rCGRP, renal blood flow progressively and significantly increased from a control of 5.0 ± 0.3 ml/min to a peak level of 6.3 ± 0.3 ml/min achieved during the 100 ng/kg/min infusion. With the highest infusion rate of 500 ng/kg/min, renal blood flow fell below the control level to 4.5 ± 0.2 ml/min (P < 0.05). The responses in renal blood flow and mean arterial pressure were associated with reductions in renal vascular resistance. After cessation of α-rCGRP infusions, arterial pressure, renal blood flow, and renal vascular resistance gradually returned toward the baseline values. In another group of rats (n = 9), infusion of α-rCGRP for 30 min at 100 ng/kg/min produced a significant reduction in urinary sodium excretion from 0.28 ± 0.06 to 0.14 ± 0.5 μEq/min (P < 0.05). Urine flow and urinary potassium excretion also appeared to decrease, but the changes were not significantly different (P > 0.05) from their respective baselines. These results demonstrate that α-rCGRP is a potent and reversible hypotensive and renal vasodilatory agent in the anesthetized rat. The data also suggest that α-rCGRP may have significant effects on the excretory function of the kidney.

UR - http://www.scopus.com/inward/record.url?scp=0023793706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023793706&partnerID=8YFLogxK

U2 - 10.3181/00379727-188-42740

DO - 10.3181/00379727-188-42740

M3 - Article

C2 - 3260672

AN - SCOPUS:0023793706

VL - 188

SP - 316

EP - 322

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 1535-3702

IS - 3

ER -